Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: A retrospective, single-institution study

被引：0
|
作者：
Lee, S.
Yoon, S.
Shin, S.
Choi, H.
机构：
[1] Yonsei Canc Ctr, Seoul, South Korea
[2] Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.339
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
339
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic influence of clinical biomarkers in patients (pts) with advanced hepatocellular carcinoma (HCC) receiving sorafenib: A single institution experience
    Abdel-Rahman, Omar
    Lamarca, Angela
    Salu, Ismail
    McNamara, Mairead G.
    Valle, Juan W.
    Hubner, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [42] THE OUTCOME AND EFFICACY OF ADJUVANT CHEMOTHERAPY ALONE IN PATIENTS WITH STAGE IIIA ENDOMETRIAL CARCINOMA WITH SOLITARY ADNEXAL INVOLVEMENT: A RETROSPECTIVE SINGLE-INSTITUTION STUDY
    Lan, C.
    Huang, X.
    Huang, Y.
    Xi, S.
    Huang, H.
    Feng, Y.
    Liu, J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1304 - 1304
  • [43] The outcome and efficacy of adjuvant chemotherapy alone in patients with stage IIIA endometrial carcinoma with solitary adnexal involvement: A retrospective single-institution study
    Lan, Chunyan
    Huang, Xin
    Huang, Yongwen
    Xi, Shaoyan
    Huang, He
    Feng, Yanling
    Liu, Jihong
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 135 (03) : 446 - 450
  • [44] Urticaria in infants: A single-institution retrospective study
    Kim, Eun Jae
    Zhang, Zinan
    Hlobik, Madeline
    Ho, Tina
    Huang, Jennifer T.
    [J]. PEDIATRIC DERMATOLOGY, 2024, 41 (02) : 260 - 262
  • [45] A retrospective study on the efficacy and safety of sorafenib or lenvatinib combined with sintilimab in patients with advanced hepatocellular carcinoma.
    Zeng, Zhen
    Zhang, Linzhi
    Wu, Tong
    Cheng, Jiamin
    Chen, Yan
    Lu, Yinying
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series
    Takano, S
    Watanabe, Y
    Ohishi, H
    Kono, S
    Nakamura, M
    Kubota, N
    Iwai, S
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (01): : 67 - 72
  • [47] Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study
    Xu, Yongkang
    Fu, Shumin
    Liu, Kan
    Mao, Ye
    Wu, Jianbing
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 853 - 863
  • [48] Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
    Kim, Do Young
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2017, 23 (02) : 123 - 124
  • [49] Comparing surgery versus sorafenib in advanced hepatocellular carcinoma: An Italian weighted study
    Famularo, S.
    Donadon, M.
    Cipriani, F.
    Giuliante, F.
    Ferrero, A.
    Molfino, S.
    Valle, R. Dalla
    Chiarelli, M.
    Maestri, M.
    Jovine, E.
    Grazi, G. L.
    Ruzzenente, A.
    Memeo, R.
    Crespi, M.
    Antonucci, A.
    Bernasconi, D. P.
    Romano, F.
    Griseri, G.
    Aldrighetti, L.
    Torzilli, G.
    Trevisani, F.
    [J]. DIGESTIVE AND LIVER DISEASE, 2021, 53 : S41 - S41
  • [50] The congenital sternoclavicular sinus: a single-institution retrospective study of 88 patients
    Gang Yang
    Taozhen He
    [J]. Orphanet Journal of Rare Diseases, 16
12345